KORU Medical Systems Inc. Common Stock (DE) (KRMD)
KRMD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/0001161697-26-000052-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | KRMD on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000704440 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $41.1M |
| Net income | -$2.6M |
| Operating income | -$3.0M |
| Net margin | -6.4% |
| Operating margin | -7.2% |
| Revenue growth | +22.2% |
| Cash | $8.9M |
| Total assets | $28.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $7.4M cash; operating cash flow $111K a quarter. | Report 2026-09-30 |
| Shares outstanding | 43,375,176 (2026-11-10); 46,322,655 a year earlier; 45,669,362 three years earlier. | Cover page 2026-11-10 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Cherry Bekaert LLP, Tampa, Florida, United States | PCAOB Form AP 2026-03-13 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $215K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $11.6M | $218K | -$883K | $7.4M | $332K | $46.3M | 10-Q 2026-11-10 |
| Q2 2026 2026-06-30 | $12.0M | $252K | $216K | $8.3M | No debt tags | $45.1M | 10-Q 2026-08-05 |
| Q1 2026 2026-03-31 | $11.8M | -$807K | $15K | $8.8M | No debt tags | $43.3M | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | $10.9M | -$487K | $1.1M | $8.9M | No debt tags | $41.1M | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | $10.4M | -$778K | $65K | $8.5M | $335K | $39.1M | 10-Q 2026-11-10 |
| Q2 2025 2025-06-30 | $10.2M | -$207K | -$460K | $8.1M | No debt tags | $36.8M | 10-Q 2026-08-05 |
| Q1 2025 2025-03-31 | $9.6M | -$1.2M | -$237K | $8.7M | $137K | $35.1M | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | $8.8M | -$1.6M | $940K | $9.6M | $271K | $33.6M | 10-K 2026-03-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 REGISTRATION STATEMENT | S-3 | 2026-11-16 |
| Latest annual report FORM 10-K ANNUAL REPORT FOR 12-31-2025 | 10-K | 2026-03-12 |
| Latest quarterly / interim FORM 10-Q QUARTERLY REPORT FOR 09-30-2026 | 10-Q | 2026-11-10 |
| Latest current report FORM 8-K CURRENT REPORT FOR 11-10-2026 | 8-K | 2026-11-10 |
| Latest proxy SCHEDULE 14A DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 969 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +19.7% |
| 1 month | +23.3% |
| 3 months | +11.3% |
| Year to date | -36.3% |
| 1 year | -14.9% |
| From 52-week high | -43.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ANIK | Anika Therapeutics Inc. | $12.92 | -3.58% | $173.1M |
| KTWO | K2 Capital Acquisition Corporation Class A Ordinary Share | $10.13 | +0.05% | $203.0M |
| PYPD | PolyPid Ltd. | $6.15 | -1.76% | $124.9M |
| UTMD | Utah Medical Products Inc. | $72.36 | +0.54% | $206.2M |
| PDEX | Pro-Dex Inc. | $64.48 | -1.80% | $206.3M |
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier